Back
ProShares UltraShort MSCI Emerging Markets Vs. Cidara Therapeutics Industry Stock Comparison
Sell
21
EEV
ProShares UltraShort MSCI Emerging Markets
Last Price:
$12.28
Seasonality Move:
2.51%
Buy
77
CDTX
Cidara Therapeutics
Last Price:
$51.66
Seasonality Move:
-8.55%
Sell
21
ProShares UltraShort MSCI Emerging Markets (EEV)
is a Sell
Is ProShares UltraShort MSCI Emerging Markets a Buy, Sell or Hold?
-
The current ProShares UltraShort MSCI Emerging Markets [EEV] share price is $12.47. The Score for EEV is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
EEV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $55.32. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EEV Stock Price Chart
What is ProShares UltraShort MSCI Emerging Markets's stock price today?
-
The ProShares UltraShort MSCI Emerging Markets share price today is $12.47Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EEV is experiencing selling pressure, which indicates risk of future bearish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $55.32The current trend is moderately bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
EEV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.07 | Buy |
Relative Strength Index (14 RSI): | 37.38 | Sell |
Chaikin Money Flow: | -3736 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.4 - 13.32) | Sell |
Bollinger Bands (100): | (13.21 - 16.43) | Sell |
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.91 | Buy |
Relative Strength Index (14 RSI): | 81.84 | Buy |
Chaikin Money Flow: | 1154906 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.31 - 51.77) | Buy |
Bollinger Bands (100): | (15.88 - 36.04) | Buy |
EEV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.43 | Buy |
20-day SMA: | 12.77 | Sell |
50-day SMA: | 13.52 | Sell |
200-day SMA: | 15.56 | Sell |
8-day EMA: | 8.91 | Buy |
20-day EMA: | 4.9 | Buy |
50-day EMA: | 2.26 | Buy |
200-day EMA: | 0.61 | Buy |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.39 | Buy |
20-day SMA: | 42.46 | Buy |
50-day SMA: | 30.72 | Buy |
200-day SMA: | 21.84 | Buy |
8-day EMA: | 50.49 | Buy |
20-day EMA: | 44.06 | Buy |
50-day EMA: | 34.72 | Buy |
200-day EMA: | 23.97 | Buy |
ProShares UltraShort MSCI Emerging Markets Earnings Growth & EEV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.
ProShares UltraShort MSCI Emerging Markets Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cidara Therapeutics Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |